Vaccines TRIZ Cases
- Plant-Produced Anti-CHIKV mAbs With Uniform Glycans to Avoid ADE
Plant-made anti-CHIKV antibodies use a uniform N-linked glycan profile to improve ADCC and neutralization while lowering ADE risk.
- IL13RA2 and BIRC5 Peptide Immunotherapy for Adrenal Cancer Recurrence
Targeted IL13RA2 and BIRC5 peptide immunotherapy aims to trigger cytotoxic T-cell responses against adrenal cancer and limit recurrence.
- Plant-Made Anti-CHIKV mAbs With Uniform Glycans and Low ADE
Plant-produced anti-CHIKV antibodies use a uniform N-linked glycan profile to improve neutralization while reducing ADE risk.
- Plant Expression Vectors With Double Terminators for Higher Protein Yield
Optimized 3′ UTR double terminators and MARs boost transcript stability and raise plant recombinant protein expression.